TAMs release a number of angiogenesis-modulating molecules that include enzymes (COX-2, iNOS) [238], matrix metalloproteinases (MMPs-1, 2, 3, 9, and 12) [239], cathepsin proteases [240] and plasmin, urokinase plasminogen activator [241]
PLOS Digital Health, "Decentralized clinical trials: A comprehensive analysis of trends, technologies, and global challenges," Jan 16, 2026
Injectable / Mesotherapy Protocols Recommended for moderate hair loss or advanced skin aging
, BPC 157
Aust N Z J Psychiatry
Patients should also disclose all prescription medications, supplements, and allergies to help determine whether compounded peptide treatment is appropriate for their individual circumstances